ArticleJournal of the National Cancer Institute2018

Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition.

Rebecca Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.